Therapeutics: Mammalian target of rapamycin (mTOR; FRAP; RAFT1); interleukin-8 (IL-8; CXCL8)

Cancer

INDICATION: Liver cancer

Cell culture studies suggest combining doxorubicin with

Read the full 91 word article

User Sign In